BBRE JPMorgan BetaBuilders MSCI US REIT ETF
Profitability Metrics
Valuation Metrics
Growth & Cash Flow
Price Change
Top 10 Holdings
| Stock Ticker | Weight |
|---|---|
| WELL | 10.84% |
| PLD | 9.87% |
| EQIX | 4.75% |
| DLR | 4.61% |
| SPG | 4.47% |
| O | 4.41% |
| PSA | 3.76% |
| VTR | 3.09% |
| IRM | 2.62% |
| VICI | 2.48% |
ETF Analysis
Fund Overview
JPMorgan BetaBuilders MSCI US REIT ETF (BBRE) currently reports 107 stock positions (subject to change), placing it in the broadly constructed range by holdings breadth. The top line-up is WELL (10.84%), PLD (9.87%), EQIX (4.75%), with WELL as the largest single weight at 10.84%. Together, the top three holdings account for 25.46%, which suggests the fund is not overly reliant on its largest positions to generate returns. The fund's architecture positions it to benefit from strength in its top holdings while the broader basket provides a degree of insulation against single-name shocks.
Profitability & Capital Efficiency
Looking at how effectively the underlying holdings deploy capital, ROIC is 4.28%, WACC is 7.81%, and the economic spread is -3.53%. On balance, capital is being deployed at rates below what debt and equity holders require, a headwind to long-term value creation if sustained. Supporting metrics show ROE at 11.12% and ROA at 2.81%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio that likely needs operating improvement before returns quality can be considered durable.
Valuation
On valuation, the portfolio registers trailing P/E of 28.03, forward P/E of 34.72, PEG of 11.44. The minimal trailing-to-forward compression implies limited earnings growth expectations are embedded in current prices. The PEG ratio is elevated relative to historical norms, implying the market is paying a meaningful premium for the earnings trajectory embedded in analyst estimates. A current ratio reading of 1.73 points to holdings that are managing short-term obligations without apparent stress. Taken together, the multiple and liquidity picture suggests a portfolio that is priced for a constructive outcome — but where execution against earnings estimates will be the key determinant of whether that price is justified.
Margins & Cash Generation
Across the three margin layers, gross margin sits at 65.58%, operating margin at 31.36%, and free cash flow margin at N/A. The gross margin reading is exceptional — a reliable indicator of competitively advantaged businesses. Operating margins this strong typically indicate a combination of pricing power, cost discipline, and operating leverage. Free cash flow margin data is unavailable in the current snapshot. Read together, these margin levels suggest a portfolio where earnings durability is present in parts but not consistent across the full holding set.
Growth & Forward Outlook
Two key indicators frame the near-term view: TTM revenue growth of 9.48% a signal of steady demand without the volatility of high-growth names, while the estimated 12-month price change of 10.53%, where the target distribution indicates incremental upside rather than outsized repricing. The near-term return case is built on whether reported trends and analyst projections can remain close enough to make current prices look justified. Whether the setup resolves positively or negatively will depend as much on the macro backdrop as on the capacity of the underlying businesses to deliver against current estimates. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.
Conclusion
The balance of evidence is not favorable enough to recommend action — this profile is best approached defensively, with a focus on understanding the downside scenarios before committing capital.
This assessment reflects quantitative metrics only and does not constitute financial advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.